CIK 0001730430
- Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981795578
- Phone
- +1 781-431-9100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-29 | BAKER BROS. ADVISORS LP Director | Grant or award | +6,078 | 143,277 | ||
| 2026-05-29 | BAKER BROS. ADVISORS LP Director | Grant or award | +6,078 | 2,744,894 | ||
| 2026-05-29 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +36,474 | 36,474 | ||
| 2026-05-29 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +36,474 | 36,474 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award | +8,397 | 137,199 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award | +8,397 | 2,738,816 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +50,394 | 50,394 | ||
| 2025-06-03 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +50,394 | 50,394 | ||
| 2024-10-04 | BAKER BROS. ADVISORS LP Director | Grant or award | +4,730 | 128,802 | ||
| 2024-10-04 | BAKER BROS. ADVISORS LP Director | Grant or award | +4,730 | 2,730,419 | ||
| 2024-10-04 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +28,384 | 28,384 | ||
| 2024-10-04 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +28,384 | 28,384 | ||
| 2024-06-05 | BAKER BROS. ADVISORS LP Director | Grant or award | +6,346 | 124,072 | ||
| 2024-06-05 | BAKER BROS. ADVISORS LP Director | Grant or award | +6,346 | 2,725,689 | ||
| 2024-06-05 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +38,080 | 38,080 | ||
| 2024-06-05 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Share Option (right to buy) | +38,080 | 38,080 | ||
| 2023-06-06 | BAKER BROS. ADVISORS LP Director | Grant or award | +8,746 | 117,726 | ||
| 2023-06-06 | BAKER BROS. ADVISORS LP Director | Grant or award | +8,746 | 2,719,343 | ||
| 2023-06-06 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +52,472 | 52,472 | ||
| 2023-06-06 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +52,472 | 52,472 |
Page 1 of 3 · 52 trades